Last close As at 05/08/2026
GBP0.96
▲ 0.05 (0.05%)
Market capitalisation
GBP2,481m
Research: Real Estate
With 90% of contracted rental income paid directly or indirectly by the UK or Irish governments and the balance primarily coming from co-located pharmacies, rent collection remained robust through H120, contributing to a strong H120 financial performance. Primary Health Properties (PHP) is well on track to meet its fully covered 5.9p (+5.4%) FY20e DPS target, which will mark the 24th year of uninterrupted growth.
Primary Health Properties |
Robust and resilient growth |
H120 results |
Real estate |
20 August 2020 |
Share price performance
Business description
Next events
Analyst
Primary Health Properties is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||||
With 90% of contracted rental income paid directly or indirectly by the UK or Irish governments and the balance primarily coming from co-located pharmacies, rent collection remained robust through H120, contributing to a strong H120 financial performance. Primary Health Properties (PHP) is well on track to meet its fully covered 5.9p (+5.4%) FY20e DPS target, which will mark the 24th year of uninterrupted growth.
Year end |
Net rental income (£m) |
Adj. EPRA earnings* (£m) |
Adj. EPRA EPS** (p) |
Adj. EPRA*** NTA/share (p) |
DPS |
P/NTA |
Yield |
12/18 |
76.4 |
36.8 |
5.2 |
105.1 |
5.40 |
1.46 |
3.5 |
12/19 |
115.7 |
59.7 |
5.4 |
107.9 |
5.60 |
1.43 |
3.6 |
12/20e |
131.7 |
73.2 |
5.7 |
113.2 |
5.90 |
1.36 |
3.8 |
12/21e |
138.6 |
77.5 |
5.8 |
116.5 |
6.10 |
1.32 |
4.0 |
Note: *Excludes valuation movements, amortisation of fair value adjustment to acquired debt, and other exceptional items. **Fully diluted. ***Net tangible assets; adjusts for fair value of derivative interest rate contracts and convertible bond, deferred tax, and fair value adjustment on acquired debt.
Business as usual in H120
As may be expected with 90% of rental income funded by government bodies, PHP delivered a strong and robust operational and financial performance in H120 despite the COVID-19 pandemic. Compared with H119, adjusted EPRA earnings increased by £8.1m or 29% to £36.0m, driven by accelerating rental growth, a lower average cost of debt, and a full period contribution from MedicX. With a positive property valuation result, EPRA net tangible assets (NTA) per share increased to 109.1p and including DPS paid the NTA total return in the period was 3.1%. Despite the pandemic, we have made no material changes to our forecasts struck earlier in the year other than to adjust for the recent £140m (gross) oversubscribed share placing at 145p, the proceeds of which will be used to support further accretive portfolio investment.
Well placed to support health service investment
The COVID-19 pandemic has highlighted the pressures on health systems around the world and will likely lead to increased healthcare spending. It also reinforces the existing consensus that exists in the UK and Ireland to place more emphasis on primary care and away from expensive and inflexible hospitals in an effort to meet the increasing healthcare needs of growing and ageing populations. This requires larger, more flexible, higher-quality premises, providing PHP with significant investment opportunities in the coming years. PHP has more than £400m of available funding headroom and a strong pipeline of targeted acquisitions and asset management projects with a value of c £128m.
Valuation: Secure income with growth
Income visibility is strong, with long leases and substantially upwards-only rents, 90% backed directly or indirectly by government bodies, with little exposure to the economic cycle, or fluctuations in occupancy. The increased FY20 DPS, fully covered by earnings, represents a yield of 3.8%, with good prospects for further growth, and supports the continuing premium to NAV.
Summary of H120 financial performance
As may be expected with 90% of rental income funded by government bodies, PHP delivered a strong and robust operational and financial performance in H120 despite the COVID-19 pandemic. With more than 99% of Q220 rents collected and 96% in Q320, to the date of the interim report, with the balance expected shortly, DPS payments have been unaffected and PHP is now in its 24th year of uninterrupted DPS growth. PHP has been actively working with the health services and general practitioner (GP) tenants to help them better utilise group properties for deployment in the front line of the current health crisis and has meanwhile continued to actively deploy capital, in many cases bringing additional new-build, high-quality facilities to the sector. The highlights of the interim results were:
■
Adjusted EPRA earnings (EPRA earnings further adjusted to exclude the non-cash positive amortisation on the fair value adjustment on the MedicX fixed rate debt at acquisition) increased by £8.1m or 29% to £36.0m. The inclusion of MedicX for a full six-month period contributed £4.1m of the increase, with the balance driven by rental growth and a reduction in the cost of borrowing.
■
The £11.0m (c 20%) increase in net rental income compared with H119 included the impact of acquisitions, forward-funded development completions, asset management projects and underlying rental growth.
■
The period-end annualised contracted rent roll had reached £133.3m compared with £127.7m at end FY19, with completed rent reviews and asset management projects adding c £0.9m.
■
Operational costs have continued to be tightly controlled, increasing with the size of the group but at a slower rate than rental income. The EPRA cost ratio reduced further to 11.6% (H119: 12.2% and FY19: 12.0%) and remains among the lowest in the sector. The accrual for the performance incentive fee (PIF) payable to the investment manager, based on NAV total return in excess of a hurdle rate of 8%, reduced slightly.
■
Included in IFRS earnings, the net valuation surplus of £10.5m was driven by rent reviews and asset management projects in the UK with some yield compression in Ireland. The overall portfolio net initial yield was unchanged at 4.86%. IFRS earnings also included a mark to market loss on the fair value of interest rate derivatives and convertible bonds, reflecting the decline in market interest rates and partly offset by the MedicX fixed rate debt amortisation, £6.9m in all.
■
IFRS net asset value of £1.239m (101.8p per share) was 0.8% higher than at end-FY19. Adjusted EPRA net tangible assets, or NTA, (EPRA NTA adjusted for the negative fair value adjustment on the MedicX fixed rate debt at acquisition) was similarly slightly up on end-FY19 at £1.329m or 109.1p per share (end-FY19: 107.9p). Including DPS paid, the EPRA NTA total return in the period was 3.1%.
■
The two quarterly distributions in the period amounted to 2.95p per share, a 5.4% increase compared with H119, and a third quarterly DPS of 1.475p has been declared for Q3 for payment on 21 August 2020. Adjusting for £2.2m of dividends satisfied by scrip share issuance, dividends paid of £35.9m were fully covered by adjusted EPRA earnings.
Post the H120 period end, in July, PHP completed the oversubscribed placing of 96.6m new shares (c 8% of the outstanding) at 145p to raise additional equity of £140m (or £136.9m net of issue expenses). With the new shares placed at a c 33% premium to adjusted EPRA NTA per share, the issue is accretive to NTA but slightly dilutes EPS until fully deployed.
Exhibit 1: Summary of H120 financial performance
£m unless stated otherwise |
H120 |
H219 |
H119 |
H120/H119 |
Net rental income |
64.8 |
61.9 |
53.8 |
20.4% |
Administrative expenses |
(5.7) |
(5.7) |
(5.0) |
14.0% |
Performance incentive fee accrual (PIF) |
(0.8) |
(0.9) |
(0.9) |
|
Net finance expense |
(22.3) |
(23.7) |
(20.0) |
11.5% |
Basic adjusted EPRA earnings* |
36.0 |
31.8 |
27.9 |
29.0% |
Property revaluation |
10.5 |
30.7 |
17.7 |
|
Profit on sale of properties |
0.0 |
1.4 |
0.0 |
|
Fair value loss on derivatives |
(8.1) |
(3.1) |
(2.3) |
|
Fair value gain/(loss) on convertible bond |
(0.3) |
(26.4) |
(1.8) |
|
Exceptional items related to MedicX merger |
||||
- contract termination fee |
0.0 |
(10.2) |
||
- exceptional revaluation loss |
0.0 |
(138.4) |
||
Amortisation of fair value adjustment on acquired debt |
1.5 |
1.5 |
1.0 |
|
Tax charge |
(0.1) |
(0.7) |
(0.4) |
|
Basic IFRS earnings |
39.5 |
35.2 |
(106.5) |
|
Basic IFRS EPS (p) |
3.2 |
3.0 |
(10.7) |
|
Diluted EPRA EPS (p) |
3.0 |
2.8 |
1.9 |
|
Diluted adjusted EPRA EPS (p) |
3.0 |
2.7 |
2.8 |
5.3% |
DPS (p) |
2.95 |
2.80 |
2.80 |
5.4% |
Dividend cover** |
1.00 |
0.97 |
1.04 |
|
Adjusted EPRA NAV per share (p)*** |
109.1 |
107.9 |
105.2 |
|
EPRA NAV total return |
3.8% |
5.3% |
2.7% |
|
Investment portfolio (bn) |
2.51 |
2.41 |
2.35 |
|
Net LTV |
45.8% |
44.2% |
47.9% |
|
EPRA cost ratio |
11.6% |
11.8% |
12.2% |
Source: PHP data. Note: *Adjusted EPRA earnings excludes valuation movements, amortisation of acquired fixed rate debt revaluation and other exceptional items. **Dividend cover is adjusted EPRA earnings as a percentage of dividends declared. ***Adjusted EPRA NAV excludes fair value movements in derivative interest rate contracts and convertible bonds, acquired fixed rate debt revaluation and deferred tax.
Portfolio update
At 30 June 2020, PHP’s 510 assets were externally valued at £2.51bn with a contracted rent roll of £133.3m reflecting a net initial yield of 4.86%. The £5.6m (or 4.4%) increase in contracted rent roll during the period predominantly reflected the acquisition of a portfolio of 22 UK assets for £54m, adding £2.9m, as well as three forward funding developments acquired (one in Ireland and two in the UK) with a total development commitment of £29.3m, which added a further £1.2m. Rental growth and asset management projects added £0.9m.
The 17 assets in Ireland now account for more than 8% of the total by valuation, and enhance the overall portfolio average lot size of £4.9m, which reflects a focus on purpose-built, larger, multi-disciplinary medical centres.
With 90% of contracted rental income paid directly or indirectly by the UK and Irish governments, and the balance primarily by co-located pharmacies, covenant strength is exceptionally strong. Given the nature of the assets, vacancy is de minimis, and the weighted average unexpired lease term (WAULT) is 12.5 years, subject to upwards rent increases. Only £3.0m (2.3%) of annualised rent roll expires in the next three years. Of this, £2.6m is subject to a planned asset management initiative or terms have been agreed to renew the lease.
Exhibit 2: Portfolio summary as at 30 June 2020
H120 |
FY19 |
|
Total number of properties |
510 |
488 |
Of which properties in Ireland |
17 |
16 |
Of which under development |
6 |
6 |
Investment portfolio value |
£2.51 billion |
£2.41 billion |
Contracted rent roll |
£133.3 million |
£127.7 million |
Net initial yield |
4.86% |
4.86% |
Average lot size |
£4.9m |
£4.9 million |
Average WAULT |
12.5 years |
12.8 years |
Occupancy |
99.5% |
99.5% |
Source: PHP
The portfolio provides a stream of high-quality recurring income with good potential for further growth through acquisitions of standing assets and pre-let developments, development completions, asset management and rental growth.
Acquisition pipeline
PHP continues to have a strong pipeline of potential acquisitions both in the UK and Ireland totalling £92m, including £44m that is under offer, with an additional pipeline of asset management opportunities totalling £36m (see below). The key drivers of medium-term demand for investment in primary healthcare properties are demographic, including a growing population of elderly with increasingly complex medical needs, combined with the drive to shift healthcare delivery out of expensive and inflexible hospitals. The COVID-19 pandemic has increased the numbers of delayed and deferred hospital appointments, accelerating the migration out of hospitals, and increasing the demand for primary healthcare services despite the use by GPs of internet and telephone for initial consultations.
Development portfolio
PHP is not a developer and does not engage in speculative development, but it does forward fund the development of new, pre-let healthcare facilities, acquiring the assets on completion. Three developments in Ireland (Athy in County Kildare, Bray, in County Wicklow and Rialto in Dublin) completed during H120, on time and with a net development cost of £43.8m (€48.3m). Including the three new commitments made during H120 (Arklow in County Wicklow, Ireland, Eastbourne and Epsom) there continue to be six developments on site with a net development cost of £41.5m (of which £30.9m remaining).
Exhibit 3: Current forward-funded development projects
Expected completion |
Net development cost |
Costs to complete |
|
Ireland |
|||
Banagher, County Offaly |
Q420 |
£4.5m (€5.1m) |
£2.7m (€3.0m) |
Arklow, County Wicklow |
Q122 |
£16.9m (€18.7m) |
£14.5m (€16.0m) |
UK |
|||
Mountain Ash, Wales |
Q121 |
£4.9m |
£3.2m |
Llanbradach, Wales |
Q121 |
£2.8m |
£2.1m |
Eastbourne, East Sussex |
Q221 |
£8.4m |
£5.2m |
Epsom, Surrey |
Q221 |
£4.0m |
£3.2m |
Total |
£41.5m |
£30.9m |
Source: PHP
Asset management and accelerating rental growth
PHP continues to have an active programme of incremental asset management projects such as property extensions, refurbishments and lease extensions/re-gears. Extensions and refurbishments enhance the quality of the portfolio, support the tenants in improving their healthcare delivery, generate additional rents and support lease extensions. Lease extensions extend both the WAULT and income visibility while enhancing valuation. During H120, 12 projects were either completed or continue on-site with an aggregate investment of requirement of £4.1m that will see £0.12m added to rental income and extend WAULT back to an average 21 years. A further 80 projects have either been agreed or are in advanced negotiations, requiring an investment of c £36m, generating an additional £1.1m of rental income and similarly extending WAULT on those premises back to an average 21 years.
Accelerating rental growth
Low rates of inflation (in contrast to land and building cost inflation) and low open market rent review increases in recent years have resulted in low overall levels of rent growth. However, the trend of the past three years has moved positively upwards, with an average uplift on review of 2.2% achieved by PHP in H120 (FY19: 1.9% and FY18: 1.4%). While the current economic weakness is being reflected in lower rates of inflation, the catch-up in open market rents (69% of the total for PHP) should have further to go.
|
Exhibit 4: Rental growth history (average annualised uplift on completed reviews in year) |
|
|
Source: PHP data, Edison Investment Research |
Across the market there is evidence that open market rent reviews have failed to sufficiently capture the strong rise in land and build costs in recent years, in part the result of financial pressures and reorganisation within the NHS that slowed decision making on commissioning the development of new primary healthcare facilities. The dearth of new developments that this created restricted the opportunities for increased land and building costs to be adequately reflected in the rent reviews for existing assets. As the NHS reforms have bedded down and plans take shape, development activity has begun to pick up and the rents required to encourage the flow of much-needed private investment that will support modernisation of the primary healthcare estate should increasingly be reflected in market rent levels across the estate.
During H120, uplifts of 2.7% and 2.9% were achieved on RPI-based and fixed uplift reviews. For open market reviews (69% of the total), an average of 1.1% was achieved on 44 reviews including 20 where there was no uplift. In addition, a further 134 open market rent reviews were agreed in principle, which will add £0.8m to the contracted rent roll when concluded, representing an uplift of 1.4% pa.
Financials
Following the H120 results, other than to update for the recent share placing, we have made only minor changes to our FY20 and FY21 forecasts that were first published in our March 2020 outlook note, before the extent of the COVID-19 pandemic had become apparent.
The key underlying assumptions we make relate to asset growth and funding:
■
New investment commitments of £62.5m in H220 and £125m in FY21, a mix of fully let completed assets and forward funding commitments in both the UK and Ireland. This represents a slight increase in FY20 investment for the year as a whole with c £83m committed in H120 against our £62.5m assumption.
■
For the UK we assume a blended cash yield on investment of 4.50% for standing assets and 4.75% for development assets, and in the RoI we assume 5.00% for standing assets and 5.25% for development assets. The blended yield on our assumed new commitments is 4.80%.
■
We assume a blended average 2.0% pa rental growth.
■
Given that cash is deployed to forward funding agreements, the cash investment reflected in our estimates slightly lags the pace of investment commitments. We expect PHP to fund our assumed level of asset growth with existing cash resources, buoyed by the proceeds of the July equity issue.
■
Our cost estimates are substantially driven by the agreed investment management fee schedule, whereby the current marginal management fee rate is 0.275% pa. We have additionally allowed for £1.6m pa PIF payments to the investment adviser, in line with the H120 accrual.
■
We make no assumption of changes in market valuation yields (either up or down) and reflect the assumed rental growth in gross revaluation gains, partly offset by assumed acquisition costs. We estimate that a 0.1% decrease in the portfolio net initial yield would increase FY20e EPRA NAV per share by c 4p, with a 0.1% increase in net initial yield having a similar negative impact.
Our forecasts are shown in detail in Exhibit 10 at the back of this report and are summarised in Exhibit 5 below. As a result of the capital increase, we forecast slightly lower debt and borrowing costs in FY21 with a corresponding slight increase in adjusted EPRA earnings. However, because of the increased average number of shares in issue there is a slight reduction in adjusted EPRA EPS and dividend cover. We still expect dividends to be fully covered in FY20 and very substantially covered in FY21 and meanwhile our adjusted EPRA net tangible assets per share is slightly increased. Given its substantial capital resources, faster investment than we have assumed is possible and we would expect this to have a positive impact on EPS and dividend cover.
Exhibit 5: Summary of forecast changes
Net rental income |
Adj. EPRA earnings |
Diluted adj. EPRA EPS (p) |
DPS (p) |
Dividend cover (x) |
Adjusted EPRA NTA/share (p) |
|||||||||||||
Old |
New |
% diff |
Old |
New |
% diff |
Old |
New |
% diff |
Old |
New |
% diff |
Old |
New |
% diff |
Old |
New |
% diff |
|
12/20e |
131.3 |
131.7 |
0.3 |
72.8 |
73.2 |
0.6 |
5.9 |
5.7 |
-3.0 |
5.9 |
5.9 |
0.0 |
101% |
100% |
-1.4 |
109.7 |
113.2 |
3.5 |
12/21e |
138.6 |
138.6 |
0.0 |
77.2 |
77.5 |
0.4 |
6.2 |
5.8 |
-6.5 |
6.1 |
6.1 |
0.0 |
104% |
97% |
-7.0 |
113.7 |
116.5 |
2.8 |
Source: Edison Investment Research
Funding strategy
With a progressive dividend policy that sees recurring earnings more or less fully distributed, portfolio growth is funded by a balance of new equity and debt, locking in a positive spread between investment yields and funding costs and generating operational and financial economies of scale.
By the end of H120, the £100m (gross) proceeds of the September 2019 equity raise had been deployed and although £266.7m of headroom (undrawn debt facilities and cash) remained, to have deployed this in full would have taken the loan to value (LTV) to c 51%. With a continuing strong pipeline of investment opportunities, and against an uncertain economic and financial market background, PHP decided in July to raise an additional £140m (£136.9m net of issue expenses) of equity capital. On a pro-forma basis the H120 LTV was reduced from 45.8% to 40.3% and would fall further to 34.3% assuming conversion of the £150m nominal value of convertible bonds outstanding (conversion price 149.3p). On the pro-forma basis the funding headroom (cash plus undrawn debt) increased to £403.6m. Looking ahead, PHP has also lowered its target gearing range with the maximum targeted LTV reduced from 55% to 50%. We estimate that full deployment of the increased headroom would result in a c 49% LTV. Compared with the more cyclical mainstream commercial property sector LTVs for primary healthcare investment are typically higher, recognising the highly secure, long-term nature of the cash flows, and reflected in the H120 interest cover ratio of 2.9 times.
Exhibit 6: Key debt metrics
H120 |
FY19 |
|
Average cost of debt |
3.5% |
3.5% |
Loan to value (LTV) |
45.8% |
44.20% |
Pro-forma loan to value post equity raise (LTV) |
40.3% |
N/A |
Interest cover |
2.9 times |
2.7 times |
Weighted average debt maturity |
6.7 years |
7.2 years |
Total drawn secured debt |
£1,064.2m |
£1,060.4m |
Total drawn unsecured debt |
£150.0m |
£150.0m |
Total undrawn facilities and cash available |
£403.6m |
£356.6m |
Unfettered assets |
£89.0m |
£32.3m |
Source: PHP
The average cost of debt was unchanged during H120, with a significant reduction from 4.0% having been achieved in FY19 following completion of the MedicX merger. The marginal cost of debt funding is 2.2%.
There are no significant near-term debt maturities but a little more than £400m of revolving debt facilities will mature during FY21 and FY22, providing an opportunity to realise further funding cost efficiencies. PHP says that it is already engaged in positive discussions with lenders and that it hopes to be able to make positive announcements later in the year.
Valuation
Historical returns on primary healthcare assets have been higher than other sectors of the UK commercial property market, with a lower level of volatility. This has been a function of strong healthcare fundamentals, secure and more resilient income, and more muted yield shifts through the property cycle.
Over the past five and a half years (from end-FY14 to end-H120) PHP generated an EPRA NAV total return of 73.8% or a compound 10.6% pa (dividends added back but not reinvested). Dividends paid have accounted for around half of the return, with capital returns contributing the balance including the impact of asset management, rental growth and yield tightening.
Exhibit 7: NAV total return history
2015 |
2016 |
2017 |
2018 |
2019 |
H120 |
2015–H120 |
|
Opening EPRA NAV (p) |
79.7 |
87.7 |
91.1 |
100.7 |
105.1 |
107.9 |
79.7 |
Closing EPRA NAV (p) |
87.7 |
91.1 |
100.7 |
105.1 |
107.9 |
109.1 |
109.1 |
Dividends paid in period (p) |
5.00 |
5.13 |
5.25 |
5.40 |
5.60 |
3.0 |
29.3 |
Income return |
6.3% |
5.8% |
5.8% |
5.4% |
5.3% |
2.7% |
36.8% |
Capital return |
10.1% |
3.8% |
10.5% |
4.4% |
2.7% |
1.1% |
37.0% |
NAV total return |
16.4% |
9.7% |
16.3% |
9.8% |
8.0% |
3.8% |
73.8% |
Compound annual average return |
10.6% |
Source: PHP data, Edison Investment Research
The targeted FY20 DPS of 5.90p (for which the first three quarterly payments have been made or declared) represents a prospective 3.8% dividend yield and we forecast dividends to be fully covered by adjusted EPRA earnings, with good potential for further growth.
|
Exhibit 8: PHP is in its 24th year of unbroken DPS growth |
|
|
Source: PHP data |
Importantly, PHP’s income and dividend paying capacity is backed by a secure, upwards only rent profile, c 90% funded directly or indirectly by the NHS in the UK or HSE in Ireland. Given the nature of this income stream it is tempting to draw comparison with the generic yield on 10-year gilts at little less than 0.2%, and it is this secure and growing income profile that provides support for a continuing valuation premium to EPRA NAV (currently 1.5x)
In Exhibit 9 we show the key valuation and performance metrics for PHP, and a group of its closest peers including Assura, another investor in primary healthcare assets, care home investors (Impact and Target) and supported housing investors (Civitas and Triple Point).
Exhibit 9: Peer comparison
Price |
Market cap (£m) |
P/NAV* |
Yield** |
Share price performance |
|||||
1 month |
3 months |
12 months |
From 12M high |
||||||
Assura |
81 |
2156 |
1.50 |
3.5 |
5% |
6% |
23% |
-8% |
|
Civitas Social Housing |
112 |
694 |
1.03 |
4.7 |
2% |
9% |
38% |
-3% |
|
Impact Healthcare |
103 |
327 |
0.96 |
6.0 |
7% |
6% |
-8% |
-10% |
|
Target Healthcare |
112 |
512 |
1.04 |
5.9 |
5% |
9% |
-3% |
-10% |
|
Triple Point Social Housing |
104 |
365 |
0.98 |
4.9 |
2% |
9% |
33% |
-4% |
|
Average |
1.10 |
5.0 |
4% |
8% |
17% |
-7% |
|||
Primary Health Properties |
154 |
2027 |
1.41 |
3.8 |
2% |
-3% |
17% |
-8% |
|
UK property index |
1,510 |
8.5 |
2% |
6% |
-5% |
-23% |
|||
FTSE All-Share Index |
3,378 |
3.5 |
0% |
3% |
-15% |
-21% |
|||
Source: Company data, Edison Investment Research, Refinitiv. Note: *Based on last reported EPRA NAV. **Based on 12-month trailing dividends declared. Prices at 11 August 2020.
Exhibit 10: Financial summary
£m |
2017 |
2018 |
2019 |
2020e |
2021e |
Year end 31 December |
|||||
PROFIT & LOSS |
|||||
Net rental income |
71.3 |
76.4 |
115.7 |
131.7 |
138.6 |
Administrative expenses |
(8.7) |
(9.9) |
(12.3) |
(13.1) |
(13.7) |
EBITDA |
62.6 |
66.5 |
103.4 |
118.6 |
124.8 |
Net result on property portfolio |
64.5 |
36.1 |
49.8 |
32.5 |
46.5 |
Other acquisition related value adjustment |
0.0 |
0.0 |
(148.6) |
0.0 |
0.0 |
Operating profit before financing costs |
127.1 |
102.6 |
4.6 |
151.1 |
171.3 |
Finance income |
0.3 |
0.1 |
1.4 |
1.0 |
1.0 |
Finance expense |
(31.9) |
(29.8) |
(42.6) |
(43.5) |
(45.3) |
Net finance expense |
(31.6) |
(29.7) |
(41.2) |
(42.4) |
(44.3) |
Net other income/expense |
(3.6) |
1.4 |
(33.6) |
(8.4) |
0.0 |
Profit Before Tax |
91.9 |
74.3 |
(70.2) |
100.3 |
127.0 |
Tax |
0.0 |
0.0 |
(1.1) |
(0.1) |
0.0 |
Profit After Tax (FRS 3) |
91.9 |
74.3 |
(71.3) |
100.2 |
127.0 |
Adjusted for the following: |
|||||
Net gain/(loss) on revaluation |
(64.5) |
(36.0) |
(48.4) |
(32.5) |
(46.5) |
Profit on disposal |
0.0 |
(0.1) |
(1.4) |
0.0 |
0.0 |
Fair value gain/(loss) on derivatives & convertible bond |
3.6 |
(1.4) |
33.6 |
8.4 |
0.0 |
Exceptional revaluation related to MedicX acquisition |
0.0 |
0.0 |
138.4 |
0.0 |
0.0 |
Deferred tax |
0.0 |
0.0 |
1.1 |
0.1 |
0.0 |
EPRA earnings |
31.0 |
36.8 |
52.0 |
76.2 |
80.5 |
Exceptional item |
10.2 |
0.0 |
0.0 |
||
Amortisation of fair value adjustment to acquired debt |
(2.5) |
(3.0) |
(3.0) |
||
Adjusted EPRA earnings |
31.0 |
36.8 |
59.7 |
73.2 |
77.5 |
Period end number of shares (m) |
619.4 |
769.1 |
1,216.3 |
1,314.2 |
1,314.2 |
Average Number of Shares Outstanding (m) |
600.7 |
708.6 |
1,092.0 |
1,263.3 |
1,314.2 |
Fully diluted average number of shares outstanding (m) |
665.5 |
732.7 |
1,138.5 |
1,363.7 |
1,414.6 |
Basic IFRS EPS (p) |
15.3 |
10.5 |
(6.53) |
7.9 |
9.7 |
Basic adjusted EPRA EPS (p) |
5.2 |
5.2 |
5.5 |
5.8 |
5.9 |
Diluted adjusted EPRA EPS (p) |
5.1 |
5.2 |
5.4 |
5.7 |
5.8 |
Dividend per share (p) |
5.250 |
5.400 |
5.600 |
5.900 |
6.100 |
Dividend cover (Adj. EPRA earnings/dividends paid) |
100% |
101% |
101% |
100% |
97% |
EPRA cost ratio |
13.2% |
14.3% |
12.0% |
11.6% |
11.6% |
BALANCE SHEET |
|||||
Non-current assets |
1,361.9 |
1,503.5 |
2,413.6 |
2,593.7 |
2,764.0 |
Investment properties |
1,361.9 |
1,502.9 |
2,413.1 |
2,593.7 |
2,764.0 |
Other non-current assets |
0.0 |
0.6 |
0.5 |
0.0 |
0.0 |
Current Assets |
10.5 |
10.5 |
159.8 |
158.5 |
34.1 |
Cash & equivalents |
3.8 |
5.9 |
143.1 |
144.1 |
19.7 |
Other current assets |
6.7 |
4.6 |
16.7 |
14.4 |
14.4 |
Current Liabilities |
(33.9) |
(134.5) |
(66.0) |
(58.9) |
(58.9) |
Current borrowing |
(0.8) |
(102.4) |
(6.1) |
0.0 |
0.0 |
Other current liabilities |
(33.1) |
(32.1) |
(59.9) |
(58.9) |
(58.9) |
Non-current liabilities |
(751.7) |
(591.5) |
(1,278.9) |
(1,294.3) |
(1,293.3) |
Non-current borrowings |
(729.6) |
(573.7) |
(1,257.8) |
(1,267.2) |
(1,266.2) |
Other non-current liabilities |
(22.1) |
(17.8) |
(21.1) |
(27.1) |
(27.1) |
Net Assets |
586.8 |
788.0 |
1,228.5 |
1,399.1 |
1,445.9 |
Derivative interest rate swaps |
24.5 |
17.2 |
13.0 |
19.3 |
19.3 |
Change in fair value of convertible bond |
12.3 |
3.4 |
22.7 |
23.0 |
23.0 |
Other EPRA adjustments |
0.0 |
0.0 |
48.6 |
45.7 |
42.7 |
Adjusted EPRA net tangible assets (NTA) |
623.6 |
808.6 |
1,312.8 |
1,487.1 |
1,530.9 |
IFRS NAV per share (p) |
94.7 |
102.5 |
101.0 |
106.5 |
110.0 |
Adjusted EPRA NTA per share (p) |
100.7 |
105.1 |
107.9 |
113.2 |
116.5 |
CASH FLOW |
|||||
Operating Cash Flow |
60.1 |
68.5 |
94.0 |
118.9 |
123.2 |
Net Interest & other financing charges |
(37.8) |
(35.1) |
(52.9) |
(42.4) |
(45.3) |
Tax |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
Acquisitions/disposals |
(75.4) |
(101.9) |
(47.4) |
(136.2) |
(122.2) |
Net proceeds from issue of shares |
(0.1) |
111.0 |
97.6 |
136.4 |
0.0 |
Debt drawn/(repaid) |
82.3 |
(5.6) |
110.5 |
(5.3) |
0.0 |
Equity dividends paid (net of scrip) |
(29.8) |
(34.7) |
(54.4) |
(71.0) |
(80.2) |
Other cash movements and FX |
(0.1) |
0.6 |
(11.9) |
0.8 |
0.0 |
Net change in cash |
(1.3) |
2.1 |
137.2 |
0.7 |
(124.5) |
Opening cash & equivalents |
5.1 |
3.8 |
5.9 |
143.1 |
143.8 |
Closing net cash & equivalents |
3.8 |
5.9 |
143.1 |
143.8 |
19.4 |
Debt as per balance sheet |
(730.4) |
(676.1) |
(1,263.9) |
(1,267.2) |
(1,266.2) |
Convertible bond fair value adjustment |
12.3 |
3.4 |
22.7 |
23.0 |
23.0 |
Unamortised borrowing costs |
(6.1) |
(6.4) |
(14.6) |
(12.5) |
(10.5) |
Acquired debt fair value a |
0.0 |
0.0 |
45.4 |
42.4 |
39.4 |
Net debt |
(720.4) |
(673.2) |
(1,067.3) |
(1,070.5) |
(1,194.9) |
Net LTV |
52.9% |
44.8% |
44.2% |
41.5% |
43.4% |
Source: Company accounts, Edison Investment Research
|
|
Research: Consumer
Gamesys Group’s interim results reporting pro forma adjusted EBITDA growth of 17% exceeded consensus expectations, demonstrating the strength of its strategy of growing the player base responsibly, while aiming for a high player retention rate. The improving financial position has resulted in the introduction of a new dividend (company commentary implies 36p/share for FY20) earlier than anticipated by us and consensus. We have increased our FY20 EBITDA forecast by 7.8%.